Descriptor English: | Bucladesine | ||||||
Descriptor Spanish: |
Bucladesina
| ||||||
Descriptor Portuguese: | Bucladesina | ||||||
Descriptor French: | Dibutyryl AMP cyclique | ||||||
Entry term(s): |
(But)(2) cAMP AMP, Dibutyryl Cyclic Adenosine-3',5'-Monophosphate, Dibutyryl Bucladesine, Barium (1:1) Salt Bucladesine, Disodium Salt Bucladesine, Monosodium Salt Bucladesine, Sodium Salt Cyclic AMP, Dibutyryl DBcAMP Dibutyryl Adenosine 3',5' Monophosphate Dibutyryl Adenosine 3,5 Monophosphate Dibutyryl Adenosine-3',5'-Monophosphate Dibutyryl Cyclic AMP Disodium Salt Bucladesine Monosodium Salt Bucladesine N',O' Dibutyryl cAMP N',O'-Dibutyryl-cAMP N(6),0(2')-Dibutyryl Cyclic AMP Sodium Salt Bucladesine |
||||||
Tree number(s): |
D03.633.100.759.646.138.395.250 D13.695.462.200.250 D13.695.667.138.395.250 D13.695.827.068.395.250 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D003994 | ||||||
Scope note: | A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed) |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Registry Number: | 63X7MBT2LQ | ||||||
CAS Type 1 Name: | Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate | ||||||
Public MeSH Note: | 94; was DIBUTYRYL CYCLIC AMP 1974-93 |
||||||
Online Note: | use BUCLADESINE to search DIBUTYRYL CYCLIC AMP 1974-93 |
||||||
History Note: | 94; was DIBUTYRYL CYCLIC AMP 1974-93 |
||||||
DeCS ID: | 31820 | ||||||
Unique ID: | D003994 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1974/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2016/05/27 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Bucladesine
- Preferred
Bucladesine, Disodium Salt
- Narrower
Bucladesine, Barium (1:1) Salt
- Narrower
Bucladesine, Monosodium Salt
- Narrower
Bucladesine, Sodium Salt
- Narrower
Concept UI |
M0006259 |
Scope note | A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed) |
Preferred term | Bucladesine |
Entry term(s) |
(But)(2) cAMP AMP, Dibutyryl Cyclic Adenosine-3',5'-Monophosphate, Dibutyryl Cyclic AMP, Dibutyryl DBcAMP Dibutyryl Adenosine 3',5' Monophosphate Dibutyryl Adenosine 3,5 Monophosphate Dibutyryl Adenosine-3',5'-Monophosphate Dibutyryl Cyclic AMP N',O' Dibutyryl cAMP N',O'-Dibutyryl-cAMP N(6),0(2')-Dibutyryl Cyclic AMP |
Concept UI |
M0330530 |
Preferred term | Bucladesine, Disodium Salt |
Entry term(s) |
Disodium Salt Bucladesine |
Concept UI |
M0330529 |
Preferred term | Bucladesine, Barium (1:1) Salt |
Concept UI |
M0330527 |
Preferred term | Bucladesine, Monosodium Salt |
Entry term(s) |
Monosodium Salt Bucladesine |
Concept UI |
M0330528 |
Preferred term | Bucladesine, Sodium Salt |
Entry term(s) |
Sodium Salt Bucladesine |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey